Earlier Detection.
Smarter Decisions.
Transforming scientific innovation into precision diagnostics and next-generation therapeutic solutions.
Earlier Detection.
Smarter Decisions.
Transforming scientific innovation into precision diagnostics and next-generation therapeutic solutions.
Driven by Science. Focused on Impact.
NIAB Incubated
One Health Focused
Research Driven
Field Oriented
Technology Translation & Commercialization
About Us
About Us
Science That Moves From Discovery to Impact
OneVita Biosciences is a research-driven biotechnology company that transforms advances in molecular biology, aptamer engineering, biosensors, and biomolecular technologies into innovative diagnostic and therapeutic solutions.
Our expertise includes rapid diagnostics, antimicrobial susceptibility testing, molecular recognition, livestock health and nutrition, food and milk quality monitoring, and advanced biosensor development. Building on these capabilities, we are expanding our therapeutic research into areas such as aptamer-enabled *in vivo* CAR-T engineering, cellular immunotherapy, and novel antiviral platforms.
What We Do
Pipeline
Beyond Diagnostics. Towards Next-Generation Therapeutics.
OneVita’s innovation pipeline extends beyond conventional diagnostics, encompassing a growing portfolio of biotechnology applications across animal health, human health and infectious disease management.
Our current and emerging areas of innovation include livestock nutrition, reproductive health, parasite control, rapid milk-quality assessment, antimicrobial susceptibility testing and next-generation One Health diagnostic platforms for human and food applications.
Building on our expertise in aptamer engineering, molecular recognition and biosensor technologies, we are expanding into emerging therapeutic research, including aptamer-enabled in vivo CAR-T engineering, cellular immunotherapy, targeted molecular delivery and innovative antiviral platforms.
Through an integrated approach to molecular discovery, technology development and translational research, we aim to advance a diverse pipeline of precision diagnostic and therapeutic solutions with potential for meaningful real-world impact.
Pipeline categories
Pipeline categories
Mastitis diagnostics, rapid antimicrobial susceptibility testing (AST), molecular biosensors, milk-quality assessment and One Health diagnostics for human and food applications.
Aptamer-enabled in vivo CAR-T engineering, targeted immune-cell delivery and programmable cellular therapeutic research.
Aptamer-based viral recognition, neutralisation, inhibition and targeted antiviral delivery.
Technology development
Aptamer- and antibody-based precision venom detection, toxin characterisation, and research and development of next-generation antivenom candidates.
Flagship Products
QuantM
Portable somatic cell counting technology designed to support early mastitis detection and dairy herd health monitoring.
Hour-Sense AST
Rapid antimicrobial sensitivity testing technology designed to support evidence-based veterinary treatment decisions.
Why Onevita?
One Health Perspective
We integrate human health, animal health and food safety through a connected approach to biotechnology innovation.
Advanced Molecular Biotechnology
We leverage aptamers, antibodies, nanobodies, biosensors and emerging molecular engineering technologies to develop next-generation diagnostic and therapeutic solutions.
Translational Innovation
We bridge scientific discovery and real-world applications, transforming promising research into practical diagnostic and therapeutic technologies.
Scalable by Design
We emphasise scientific validation, technology development, manufacturability and commercialisation to advance solutions with real-world potential.
Technology Platform
Molecular Science. Meaningful Innovation.
OneVita brings together molecular recognition, aptamer engineering, antibody and nanobody technologies, nucleic acid engineering and advanced biosensing to develop innovative diagnostic and therapeutic platforms.
Our integrated technology approach spans precision molecular detection, biomolecular engineering, targeted delivery systems and emerging cellular and antiviral therapeutic strategies. By combining molecular discovery with technological innovation, we aim to translate advanced biological research into next-generation solutions for human health, animal health and infectious diseases.
Aptamer Engineering
SELEX, DNA/RNA aptamer discovery, optimisation and functional molecular recognition.
Antibody & Nanobody Technologies
Molecular targeting, biomarker recognition and therapeutic candidate development.
Advanced Biosensors & Diagnostics
Portable diagnostic devices, electrochemical sensing and rapid molecular detection.
Targeted Molecular Delivery
Aptamer-functionalised delivery systems and targeted nucleic acid delivery research.
Next-Generation Therapeutics
Emerging research in in vivo CAR-T engineering, cellular immunotherapy and aptamer-based antiviral platforms.
Collaborate With Us
Let's Turn Scientific Innovation Into Real-World Solutions.
We welcome opportunities for research collaboration, technology development, validation and strategic partnerships.